查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701596

CT 和 MRI显影剂市场规模、份额、趋势分析报告：按方式、产品、给药途径、应用、最终用途、地区、细分预测，2025-2030 年

CT And MRI Contrast Agents Market Size, Share & Trends Analysis Report By Modality, By Product, By Route Of Administration, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

CT和MRI显影剂的市场趋势：

预计 2024 年全球 CT 和 MRI显影剂市场价值将达到 62.2 亿美元，预计 2025 年至 2030 年的复合年增长率为 7.81%。

碘化显影剂需求的不断增长、慢性病负担的不断加重以及政府机构对改善诊断基础设施的日益重视预计将支持市场成长。一些政府机构正在努力改善 CT 和 MRI 等医学影像的取得途径。

例如，英国政府2024年3月发布的数据显示，社区诊断中心（CDC）计画自2021年7月启动以来，已在英格兰各地提供了超过700万次诊断测试、检查和扫描。该倡议投资24.5亿美元，是英国国家医疗服务体系（NHS）史上对CT和MRI能力的最大资金投入。英格兰目前约有 155 个中心在运作，政府计划在 2025 年 3 月开设 160 个。对扩大诊断设施的日益关注预计将推动市场成长。

心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升预计将推动对显影剂和 MRI显影剂的需求。这些显影剂对于神经成像至关重要，因为它们可以增强大脑结构和异常的可见性。同样，在心臟影像中，这些显影剂有助于诊断和评估心臟病。根据ScienceDirect于2023年1月发表的一项研究，大约50%的电脑断层扫描和40%的MRI扫描使用碘或钆基显影剂来改善影像对比度并增强诊断。在神经学检查中，这数字达到60%。因此，预计未来几年慢性病盛行率的上升将增加对 CT 和 MRI显影剂的需求。

下面的图表显示了全球脑瘤发生率的上升。据此，大多数脑部和中枢神经系统癌症患者集中在亚洲。据估计，2045年亚洲将新增约2,58,996例脑癌和中枢神经系统癌症病例。因此，由于亚洲、欧洲、显影剂、北美洲和非洲等不同地区脑肿瘤等神经系统疾病的发生率不断上升，预计对CT和MRI显影剂的需求将会增加。

此外，碘化显影剂需求的增加预计将推动市场成长。 2022年，美国FDA通报碘显影剂短缺。 2023年8月，密苏里大学医学院神经病学家Adnan Qureshi博士领导的一项研究发现，碘基显影剂的短缺对全美医院对中风患者的评估产生了重大影响，导致CT检查减少。这种短缺加上不断上升的感染疾病促使製造商提高生产能力。

例如，GE医疗集团于2022年11月投资8,000万美元，扩大其挪威工厂的碘显影剂产量，以满足全球需求。碘海醇和碘克沙醇原料药是 GE 碘化显影剂的关键成分，每年有超过 1 亿名患者需要使用这些显影剂。随着投资和新生产线的投入，预计到 2025 年，生产能力将增加到每年 3,000 万剂，这凸显了对这些必需分子日益增长的需求。

市场集中度和特征

由于慢性病盛行率上升、生产能力扩大以及医疗保健投资增加，CT 和 MRI显影剂产业正处于温和成长阶段。

CT 和 MRI显影剂市场正在经历技术创新的显着成长。关键发展包括增强更安全、更有效的药物配方、使用奈米技术进行更精确的成像以及引入生物分解性的药物以最大限度地减少对环境的影响。例如，2023年4月，GE医疗推出了钆基MRI显影剂Pixxoscan（gadobutrol）。该显影剂采用环保+PLUSPAK塑胶包装，降低了成本，最大限度地减少了对环境的影响并提高了安全性。

在 CT 和 MRI显影剂市场中，监管对于确保患者安全和品质标准至关重要。美国FDA、欧盟和其他地区当局等监管机构对CT和MRI显影剂的临床试验和上市批准进行监管。例如，2023年6月，FDA核准了碘基显影剂碘普罗胺注射液（Ultravist），用于静脉和动脉造影乳房X光摄影。 Ultravist 也用于 CT 扫描。预计此类核准将在预测期内推动 CT 和 MRI显影剂行业的发展。

CT 和 MRI显影剂行业的公司正在推出创新的替代产品。例如，2024年10月，GE医疗宣布完成锰基大环MRI显影剂的I期临床开发。如果获得批准，这种显影剂可以取代钆基显影剂，并减少患者排出的钆对环境的影响。

随着主要参与者寻求扩大其全球影响力，该行业正在经历显着的区域成长。例如，2022年10月，GE医疗集团的药物诊断部门宣布与智利矿业公司Sociedad Quimica y Minera de Chile SA (SQM)达成长期协议，以确保碘的稳定供应。碘是世界各地X光和CT扫描中使用的显影剂的重要成分。

目录

第一章调查方法与范围

第二章执行摘要

第三章 CT 和 MRI显影剂市场变数、趋势和范围

  • 市场介绍/电网展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • CT和MRI造影显影剂市场分析工具
    • 波特分析
    • PESTEL分析

第四章：CT 和 MRI显影剂市场：按产品进行的估算和趋势分析

  • 定义和范围
  • 2018年及2030年产品市场占有率
  • 细分仪表板
  • CT 和 MRI显影剂市场：产品展望
  • 2025年至2030年市场规模、预测及趋势分析：
    • 钆显影剂
    • 碘显影剂

第五章 CT 和 MRI显影剂市场：按模式的估计和趋势分析

  • 定义和范围
  • 2024年及2030年模态市场占有率
  • 细分仪表板
  • CT 和 MRI显影剂市场：模式展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 磁振造影
    • X光/电脑断层扫描

第六章 CT 和 MRI 造影显影剂市场：按应用的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年各应用领域的市场占有率
  • 细分仪表板
  • CT 和 MRI显影剂市场：应用前景
  • 2018年至2030年市场规模、预测及趋势分析
    • 心血管疾病
    • 神经系统疾病
    • 胃肠道疾病
    • 癌症
    • 肾臟疾病
    • 肌肉骨骼疾病
    • 其他的

第七章 CT 和 MRI显影剂市场：按给药途径的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年给药途径市场占有率
  • 细分仪表板
  • CT 和 MRI显影剂市场展望（按给药途径）
  • 2018年至2030年市场规模、预测及趋势分析
    • 静脉
    • 口服显影剂
    • 直肠

8. CT和MRI显影剂市场：按最终用途的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • CT 和 MRI显影剂市场前景（按最终用途）
  • 2018年至2030年市场规模、预测及趋势分析
    • 医院
    • 诊断影像中心
    • 其他的

第九章：CT 和 MRI显影剂市场 - 区域估计和趋势分析（按产品）

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 区域市场占有率和主要参与者（2024年）
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场规模、预测与趋势分析（2018-2030 年）
  • 2024 年和 2030 年 CT 和 MRI显影剂市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
  • 主要企业简介
    • Bayer
    • GE Healthcare
    • Guerbet
    • Bracco Diagnostics Inc
    • Fresenius Kabi
Product Code: GVR-4-68040-537-6

CT And MRI Contrast Agents Market Trends:

The global CT and MRI contrast agents market size was estimated at USD 6.22 billion in 2024 and is anticipated to grow at a CAGR of 7.81% from 2025 to 2030. The increasing demand for iodinated contrast media, the rising burden of chronic disorders, and the rising focus of government bodies on improving diagnostic infrastructure are anticipated to support the market growth. Several government authorities are undertaking initiatives to increase access to medical imaging such as CT and MRI.

For instance, in March 2024, data published by the UK government revealed that the Community Diagnostic Centre (CDC) program has provided over 7 million diagnostic tests, checks, and scans across England since its launch in July 2021. This initiative is supported by an investment of USD 2.45 billion, marking the most significant financial commitment to CT and MRI capacity in the history of the NHS. Around 155 centres are operational in England, and the government is focused on opening 160 centres by March 2025. This growing focus on expanding diagnostic facilities is expected to drive market growth.

The increasing prevalence of chronic conditions, such as cardiovascular and neurological disorders, is expected to drive the demand for CT and MRI contrast agents. These agents are crucial in neurological imaging as they enhance the visibility of brain structures and abnormalities. Similarly, in cardiac imaging, these agents aid in diagnosing and assessing heart disease. According to a study published by ScienceDirect in January 2023, approximately 50% of CT scans and 40% of MRI scans utilize iodine or gadolinium-based contrast agents to improve image contrast and enhance diagnostics. This figure rises to 60% for neurological examinations. As a result, the growing prevalence of chronic disorders is expected to increase the demand for CT and MRI contrast agents in the coming years.

The below graph and table highlight the increasing incidence of brain tumors across the globe. It shows that the majority of individuals with brain and CNS cancer are in Asia. Around 2,58,996 new brain and CNS cancer cases are anticipated in Asia in 2045. Thus, the growing incidence of neurological conditions such as brain tumors across various regions such as Asia, Europe, Oceania, North America, and Africa is anticipated to boost the demand for CT and MRI contrast agents.

In addition, the increasing demand for iodinated contrast media is projected to propel the market growth. In 2022, the U.S. FDA reported the shortage of iodinated contrast media. In addition, in August 2023, a study led by University of Missouri School of Medicine neurologist Dr. Adnan Qureshi found that the iodinated contrast dye shortage had a significant impact on the assessment of stroke patients at hospitals across the U.S. This shortage resulted in a decline in CT procedures. This shortage, coupled with the rising prevalence of infectious diseases, has prompted manufacturers to enhance production capacities.

For instance, GE Healthcare invested USD 80 million in November 2022 to expand iodinated contrast media production at its site in Norway, aiming to meet global demand. Iohexol and iodixanol APIs are crucial in GE's iodinated contrast media, used in over 100 million patient doses annually-equivalent to three procedures every second. With investments and new production lines, the production capacity is anticipated to increase by 30 million doses per year by 2025, highlighting the growing demand for these essential molecules.

Market Concentration & Characteristics

The CT and MRI contrast agents industry is in a moderate growth stage, driven by the rising prevalence of chronic disorders, growing production capacities, and increasing healthcare investments.

The CT and MRI contrast agents market is experiencing a significant surge in innovation. Key developments include enhanced formulations for safer and more effective agents, using nanotechnology for more precise imaging, and introducing biodegradable agents that minimize environmental impact. For instance, in April 2023, GE HealthCare launched Pixxoscan (gadobutrol), a gadolinium-based MRI contrast agent featuring eco-friendly +PLUSPAK plastic packaging that reduces costs, minimizes environmental impact, and enhances safety.

Regulations are crucial in the CT and MRI contrast agents market, ensuring patient safety and quality standards. Regulatory bodies such as the U.S. FDA, the European Union, and other regional authorities regulate clinical trials and marketing authorization for CT and MRI contrast agents. For instance, in June 2023, the FDA approved the iodine-based contrast agent iopromide injection (Ultravist) for intravenous and intraarterial contrast-enhanced mammography. Ultravist is also used in CT procedures. Such approvals are anticipated to drive the CT and MRI contrast agents industry over the forecast period.

Companies in the CT and MRI contrast agents industry are introducing innovative substitute products. For instance, in October 2024, GE Healthcare announced the completion of its Phase I clinical development for a manganese-based macrocyclic MRI contrast agent. If authorized, this agent could act as an alternative to gadolinium-based contrast agents and mitigate the environmental impact of gadolinium excreted by patients.

The industry is undergoing considerable regional growth as major players aim to enhance their global presence. For instance, in October 2022, GE Healthcare's Pharmaceutical Diagnostics division announced a long-term agreement with Chilean mining company Sociedad Quimica y Minera de Chile S.A. (SQM), to ensure a stable supply of iodine, a crucial component for contrast media used in X-ray and CT procedures worldwide.

Global CT And MRI Contrast Agents Market Report Segmentation

This report forecasts revenue & volume growth of the CT and MRI Contrast Agents market and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global agrochemicals market report based on product, modality, application, route of administration, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Modality Outlook (Revenue, USD Million, 2018 - 2030)
  • Magnetic Resonance Imaging
    • Elucirem/ Vueway
    • Dotarem
    • ProHance
    • MultiHance
    • Gadovist
    • Eovist / Primovist
    • Clariscan
    • Other Generics
  • X-ray/ Computed Tomography
    • Optiray
    • ISOVUE
    • Ultravist
    • Omnipaque
    • Visipaque
    • Other Generics
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cardiovascular Disorders
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Nephrological Disorders
  • Musculoskeletal Disorders
  • Others
  • Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
  • Intravenous
  • Oral Route
  • Rectal Route
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostic Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of Primary Research
    • 1.5.1. Data for Primary Interviews in North America
    • 1.5.2. Data for Primary Interviews in Europe
    • 1.5.3. Data for Primary Interviews in Asia Pacific
    • 1.5.4. Data for Primary Interviews in Latin America
    • 1.5.5. Data for Primary Interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity Flow Approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume Price Analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. CT and MRI Contrast Agents Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising Prevalence of Chronic Disorders
      • 3.2.1.2. Technological Advancements
      • 3.2.1.3. Increasing Demand for Medical Imaging
      • 3.2.1.4. Rising Investment in Research & Development
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects associated with contrast agents
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Expansion opportunities in emerging markets
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Rising competition
  • 3.3. CT and MRI Contrast Agents Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining Power of the Suppliers
      • 3.3.1.2. Bargaining Power of the Buyers
      • 3.3.1.3. Threats of Substitution
      • 3.3.1.4. Threats From New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. CT and MRI Contrast Agents Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. CT and MRI Contrast Agents Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
    • 4.5.1. Gadolinium-based Contrast Media
      • 4.5.1.1. Gadolinium-based contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Iodinated Contrast Media
      • 4.5.2.1. Iodinated contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. CT and MRI Contrast Media Market: Modality Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Modality Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. CT and MRI Contrast Media Market by Modality Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Magnetic Resonance Imaging
      • 5.5.1.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.2. Elucirem/Vueway
        • 5.5.1.2.1. Elucirem/Vueway market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.3. Dotarem
        • 5.5.1.3.1. Dotarem market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.4. ProHance
        • 5.5.1.4.1. ProHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.5. MultiHance
        • 5.5.1.5.1. MultiHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.6. Gadovist
        • 5.5.1.6.1. Gadovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.7. Eovist / Primovist
        • 5.5.1.7.1. Eovist / Primovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.8. Clariscan
        • 5.5.1.8.1. Clariscan market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.9. Other Generics
        • 5.5.1.9.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. X-ray/Computed Tomography
      • 5.5.2.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.2. Optiray
        • 5.5.2.2.1. Optiray market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.3. ISOVUE
        • 5.5.2.3.1. ISOVUE market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.4. Ultravist
        • 5.5.2.4.1. Ultravist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.5. Omnipaque
        • 5.5.2.5.1. Omnipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.6. Visipaque
        • 5.5.2.6.1. Visipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.7. Other Generics
        • 5.5.2.7.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. CT and MRI Contrast Media Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. CT and MRI Contrast Media Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Cardiovascular Disorders
      • 6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Neurological Disorders
      • 6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Gastrointestinal Disorders
      • 6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Cancer
      • 6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Nephrological Disorders
      • 6.5.5.1. Nephrological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Musculoskeletal Disorders
      • 6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. CT and MRI Contrast Media Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. Route of Administration Market Share, 2024 & 2030
  • 7.3. Segment Dashboard
  • 7.4. CT and MRI Contrast Media Market by Route of Administration Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Intravenous
      • 7.5.1.1. Intravenous contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Oral Contrast Media
      • 7.5.2.1. Oral contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Rectal
      • 7.5.3.1. Rectal contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. CT and MRI Contrast Media Market: End Use Estimates & Trend Analysis

  • 8.1. Definitions and Scope
  • 8.2. End Use Market Share, 2024 & 2030
  • 8.3. Segment Dashboard
  • 8.4. CT and MRI Contrast Media Market by End Use Outlook
  • 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.5.1. Hospitals
      • 8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.2. Diagnostic Imaging Centers
      • 8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.3. Others
      • 8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. CT and MRI Contrast Agents Market: Regional Estimates & Trend Analysis, By Product

  • 9.1. Regional market share analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Regional Market Share and Leading Players, 2024
    • 9.4.1. North America
    • 9.4.2. Europe
    • 9.4.3. Asia Pacific
    • 9.4.4. Latin America
    • 9.4.5. Middle East and Africa
  • 9.5. Market Size & Forecasts, and Trend Analysis, 2018 to 2030
  • 9.6. CT and MRI Contrast Agents Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.7. North America
    • 9.7.1. North America CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. U.S.
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. Reimbursement Scenario
      • 9.7.2.5. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 9.7.3. Canada
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Reimbursement Scenario
      • 9.7.3.5. Canada Market Estimates and Forecasts, 2018 - 2030
    • 9.7.4. Mexico
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. Reimbursement Scenario
      • 9.7.4.5. Mexico Market Estimates and Forecasts, 2018 - 2030
  • 9.8. Europe
    • 9.8.1. Europe CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. UK
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Competitive Scenario
      • 9.8.2.3. Regulatory Framework
      • 9.8.2.4. Reimbursement Scenario
      • 9.8.2.5. UK Market Estimates and Forecasts, 2018 - 2030
    • 9.8.3. Germany
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Competitive Scenario
      • 9.8.3.3. Regulatory Framework
      • 9.8.3.4. Reimbursement Scenario
      • 9.8.3.5. Germany Market Estimates and Forecasts, 2018 - 2030
    • 9.8.4. France
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Competitive Scenario
      • 9.8.4.3. Regulatory Framework
      • 9.8.4.4. Reimbursement Scenario
      • 9.8.4.5. France Market Estimates and Forecasts, 2018 - 2030
    • 9.8.5. Italy
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Competitive Scenario
      • 9.8.5.3. Regulatory Framework
      • 9.8.5.4. Reimbursement Scenario
      • 9.8.5.5. Italy Market Estimates and Forecasts, 2018 - 2030
    • 9.8.6. Spain
      • 9.8.6.1. Key Country Dynamics
      • 9.8.6.2. Competitive Scenario
      • 9.8.6.3. Regulatory Framework
      • 9.8.6.4. Reimbursement Scenario
      • 9.8.6.5. Spain Market Estimates and Forecasts, 2018 - 2030
    • 9.8.7. Denmark
      • 9.8.7.1. Key Country Dynamics
      • 9.8.7.2. Competitive Scenario
      • 9.8.7.3. Regulatory Framework
      • 9.8.7.4. Reimbursement Scenario
      • 9.8.7.5. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 9.8.8. Sweden
      • 9.8.8.1. Key Country Dynamics
      • 9.8.8.2. Competitive Scenario
      • 9.8.8.3. Regulatory Framework
      • 9.8.8.4. Reimbursement Scenario
      • 9.8.8.5. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 9.8.9. Norway
      • 9.8.9.1. Key Country Dynamics
      • 9.8.9.2. Competitive Scenario
      • 9.8.9.3. Regulatory Framework
      • 9.8.9.4. Reimbursement Scenario
      • 9.8.9.5. Norway Market Estimates and Forecasts, 2018 - 2030
  • 9.9. Asia Pacific
    • 9.9.1. Asia Pacific CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.9.2. China
      • 9.9.2.1. Key Country Dynamics
      • 9.9.2.2. Competitive Scenario
      • 9.9.2.3. Regulatory Framework
      • 9.9.2.4. Reimbursement Scenario
      • 9.9.2.5. China Market Estimates and Forecasts, 2018 - 2030
    • 9.9.3. India
      • 9.9.3.1. Key Country Dynamics
      • 9.9.3.2. Competitive Scenario
      • 9.9.3.3. Regulatory Framework
      • 9.9.3.4. Reimbursement Scenario
      • 9.9.3.5. India Market Estimates and Forecasts, 2018 - 2030
    • 9.9.4. Japan
      • 9.9.4.1. Key Country Dynamics
      • 9.9.4.2. Competitive Scenario
      • 9.9.4.3. Regulatory Framework
      • 9.9.4.4. Reimbursement Scenario
      • 9.9.4.5. Japan Market Estimates and Forecasts, 2018 - 2030
    • 9.9.5. South Korea
      • 9.9.5.1. Key Country Dynamics
      • 9.9.5.2. Competitive Scenario
      • 9.9.5.3. Regulatory Framework
      • 9.9.5.4. Reimbursement Scenario
      • 9.9.5.5. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 9.9.6. Thailand
      • 9.9.6.1. Key Country Dynamics
      • 9.9.6.2. Competitive Scenario
      • 9.9.6.3. Regulatory Framework
      • 9.9.6.4. Reimbursement Scenario
      • 9.9.6.5. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 9.9.7. Australia
      • 9.9.7.1. Key Country Dynamics
      • 9.9.7.2. Competitive Scenario
      • 9.9.7.3. Regulatory Framework
      • 9.9.7.4. Reimbursement Scenario
      • 9.9.7.5. Australia Market Estimates and Forecasts, 2018 - 2030
  • 9.10. Latin America
    • 9.10.1. Latin America CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.10.2. Brazil
      • 9.10.2.1. Key Country Dynamics
      • 9.10.2.2. Competitive Scenario
      • 9.10.2.3. Regulatory Framework
      • 9.10.2.4. Reimbursement Scenario
      • 9.10.2.5. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 9.10.3. Argentina
      • 9.10.3.1. Key Country Dynamics
      • 9.10.3.2. Competitive Scenario
      • 9.10.3.3. Regulatory Framework
      • 9.10.3.4. Reimbursement Scenario
      • 9.10.3.5. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 9.11. Middle East and Africa
    • 9.11.1. Middle East and Africa CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.11.2. South Africa
      • 9.11.2.1. Key Country Dynamics
      • 9.11.2.2. Competitive Scenario
      • 9.11.2.3. Regulatory Framework
      • 9.11.2.4. Reimbursement Scenario
      • 9.11.2.5. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 9.11.3. Saudi Arabia
      • 9.11.3.1. Key Country Dynamics
      • 9.11.3.2. Competitive Scenario
      • 9.11.3.3. Regulatory Framework
      • 9.11.3.4. Reimbursement Scenario
      • 9.11.3.5. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 9.11.4. UAE
      • 9.11.4.1. Key Country Dynamics
      • 9.11.4.2. Competitive Scenario
      • 9.11.4.3. Regulatory Framework
      • 9.11.4.4. Reimbursement Scenario
      • 9.11.4.5. UAE Market Estimates and Forecasts, 2018 - 2030
    • 9.11.5. Kuwait
      • 9.11.5.1. Key Country Dynamics
      • 9.11.5.2. Competitive Scenario
      • 9.11.5.3. Regulatory Framework
      • 9.11.5.4. Reimbursement Scenario
      • 9.11.5.5. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors
    • 10.3.2. Key Company Market Share Analysis, 2024
  • 10.4. Key Company Profiles
    • 10.4.1. Bayer
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. GE Healthcare
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Guerbet
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Bracco Diagnostics Inc
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Fresenius Kabi
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global CT and MRI Contrast Agents Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 6 Global CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 7 Global CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 North America CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 12 North America CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 North America CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 North America CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 U.S. CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 17 U.S. CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 18 U.S. CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 U.S. CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Canada CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 22 Canada CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Canada CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Canada CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Mexico CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 27 Mexico CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Mexico CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Mexico CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Europe CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Europe CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 33 Europe CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Europe CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Europe CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 UK CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 UK CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 38 UK CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 39 UK CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 UK CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 Germany CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Germany CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 43 Germany CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Germany CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Germany CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 France CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 France CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 48 France CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 France CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 France CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 51 Italy CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 53 Italy CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 Italy CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Italy CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Spain CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Spain CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 58 Spain CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 Spain CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Spain CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Denmark CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Denmark CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 63 Denmark CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Denmark CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Denmark CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 Sweden CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Sweden CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 68 Sweden CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Sweden CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Sweden CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 Norway CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Norway CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 73 Norway CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Norway CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Norway CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 China CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 China CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 84 China CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 China CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 China CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 Japan CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Japan CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 89 Japan CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Japan CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Japan CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 92 India CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 India CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 94 India CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 India CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 India CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 97 South Korea CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 South Korea CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 99 South Korea CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 South Korea CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 101 South Korea CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 102 Australia CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 Australia CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 104 Australia CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 105 Australia CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 106 Australia CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 107 Thailand CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 108 Thailand CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 109 Thailand CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 110 Thailand CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 Thailand CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Thailand CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 113 Latin America CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 114 Latin America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Latin America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 116 Latin America CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 117 Latin America CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 118 Latin America CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 119 Latin America CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 120 Brazil CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 121 Brazil CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 122 Brazil CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Brazil CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 124 Brazil CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 125 Argentina CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 Argentina CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 127 Argentina CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 128 Argentina CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 129 Argentina CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 130 MEA CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
  • Table 131 MEA CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 MEA CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 133 MEA CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 134 MEA CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 135 MEA CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 136 South Africa CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 137 South Africa CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 138 South Africa CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 139 South Africa CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 140 South Africa CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 145 Saudi Arabia CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 146 UAE CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 UAE CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 148 UAE CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 149 UAE CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 150 UAE CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 151 Kuwait CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
  • Table 152 Kuwait CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
  • Table 153 Kuwait CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
  • Table 154 Kuwait CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
  • Table 155 Kuwait CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 156 Participant's Overview
  • Table 157 Financial Performance
  • Table 158 Product Benchmarking
  • Table 159 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 CT and MRI Contrast Agents Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global CT and MRI contrast media market: Product movement Analysis
  • Fig. 14 Gadolinium-based contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Iodinated contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Global CT and MRI contrast media market: Modality movement Analysis
  • Fig. 17 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 X-ray/computed tomography market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Global CT and MRI contrast media market: Application movement Analysis
  • Fig. 20 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Nephrological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Musculoskeletal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global CT and MRI contrast media market: Route of administration movement Analysis
  • Fig. 27 Intravenous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Oral contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Rectal contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Global CT and MRI contrast media market: End use movement Analysis
  • Fig. 31 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Diagnostic imaging centers contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Outlook, 2024 & 2030
  • Fig. 35 North America CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 42 France CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 50 China CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 51 India CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)